The road to be travelled in order to transform an idea into a tangible and productive project is research that focuses on real requirements, combined with a vocation for solving the everyday practical issues associated with the needs of both doctors and patients.
Dr Arturo Licenziati, Founder of IBSA
IBSA Iberia (Instituto Bioquímico Ibérico) is part of IBSA Group, a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 Countries on 5 continents, through the Company’s 20 subsidiaries located in Europe, China, and the United States. The group drives the development of innovative therapeutic solutions aimed at improving people's quality of life.
From Barcelona, IBSA Iberia contributes to this global vision, bringing to the Spanish and Portuguese markets the scientific expertise and commitment to excellence that define the group.
Established in Barcelona in 2019, one of the leading innovation hubs in southern Europe, we began our direct operations in Spain and Portugal following several years of product distribution through partners.
In 2026, we joined Farmaindustria, the National Business Association of the Pharmaceutical Industry in Spain. This membership reflects our commitment to the highest ethical and regulatory standards in the sector.
As members, we apply the Farmaindustria Code of Good Practice, which ensures that our operations align with the most rigorous ethical principles of the Spanish and international pharmaceutical industry. This membership reinforces our commitment to transparency, responsibility and excellence in pharmaceutical innovation.
Currently, our operations in Spain and Portugal span five therapeutic areas, where we work to provide effective, high-quality solutions across different categories, including prescription medicines, medical devices and food supplements.
IBSA Iberia's strength is not merely local. We are part of a global structure where innovation and quality are at the heart of our business:
IBSA’s mission is to improving patients’ quality of life through the research and development of effective drugs and technologies that improve the quality of existing therapeutic solutions.
As part of IBSA Group, all our activities are founded on four essential pillars:
Our activities are governed by the Group's Code of Ethics and Anti-Bribery Guidelines, with the conviction that integrity is a key element for business development.
Back to top
